Skip to main content

Table 1 Patient characteristics at baseline

From: General practitioner practice-based pharmacist input to medicines optimisation in the UK: pragmatic, multicenter, randomised, controlled trial

Variable Total Control Intervention p value
  N = 356 n = 175
(49.2%)
n = 181
(50.8%)
Stratum     0.752a
 1 [n (%)] 229 (64.3) 114 (65.1) 115 (63.5)  
 2 [n (%)] 127 (35.7) 61 (34.9) 66 (36.5)  
Age: [mean years ± SD] 67.9 ± 13.1 67.5 ± 12.6 68.5 ± 13.5 0.275b
 Median [IQR] 70 [60.0–78.0] 69 [60.0–77.0] 71 [61.0–78.5]  
 18–65 years [n (%)] 126 (35.4) 63 (36.0) 63 (34.8)  
 > 65 years [n (%)] 230 (64.6) 112 (64.0) 118 (65.2)  
 Range 25–96 26–94 25–96  
Sex     0.442a
 Female [n (%)] 192 (53.9) 98 (56.0) 94 (51.9)  
 Male [n (%)] 164 (46.1) 77 (44.0) 87 (48.1)  
Number of active medical problems: [mean ± SD] 7.6 ± 3.4 7.9 ± 3.6 7.3 ± 3.3 0.043b
Median [IQR] 7 [5–10] 8 [5–10] 6 [5–9]  
Number of repeat medicines: [mean ± SD] 10.3 ± 3.6 10.3 ± 3.5 10.3 ± 3.7 0.787b
Median [IQR] 10 [8–12] 10 [8–12] 10 [8–12]
  1. SD standard deviation, IQR interquartile range
  2. aChi-square test
  3. bMann–Whitney U test